This Viewpoint reviews disaster-related coverage policies across major managed care insurers and suggests reforms that would make both coverage and payment travel with beneficiaries when they are displaced. from JAMA Internal Medicine Online First https://ift.tt/S1Ywr2b

This case-series study reports on characteristics of brand-name and generic manufacturer patent settlement practices. from JAMA Health Forum New Online https://ift.tt/RNs2X4o

This survey study assesses associations between several sociodemographic characteristics and non–evidence-based beliefs about environmental autism risk factors through an internet-based survey of US adults. from JAMA Health Forum New Online https://ift.tt/FgoYEtQ

Health Policy from JAMA Health Forum New Online https://ift.tt/6xVhafo

This Viewpoint discusses the legal entanglements that can block generic drug competition on patents flagged for delisting. from JAMA Health Forum New Online https://ift.tt/RxaZLdV

This JAMA Forum discusses potential solutions, such as allowing accessory dwelling units to be built, helping people move to more resourced neighborhoods, and adopting the use of crisis intervention teams, to help people with mental illness who are experiencing homelessness. from JAMA Health Forum New Online https://ift.tt/SfFGdr0

Shoulder injury that is related to vaccine administration (SIRVA) encompasses various shoulder conditions that follow injection of vaccines into the deltoid. Past work has shown that this outcome is rare, with an estimated incidence of 9.9 per 100 000 vaccinations. However, it was unknown whether SIRVA risk is higher after COVID-19 vaccination compared with influenza vaccination. from JAMA Internal Medicine Online First https://ift.tt/iw0ZS1v

This cohort study uses a validated natural language processing algorithm to access if the incidence of shoulder injury related to vaccine administration (SIRVA) is higher after COVID-19 vs influenza vaccination at a health care system in California. from JAMA Internal Medicine Online First https://ift.tt/oBT0Vfj

This Viewpoint discusses prevention-based accountability and price-based reforms to put Medicare on a sustainable spending path. from JAMA Internal Medicine Online First https://ift.tt/bIP83HG

This Viewpoint discusses the public health effects of the US Food and Drug Administration’s (FDA) recent decision to authorize 4 flavored nicotine products. from JAMA Health Forum New Online https://ift.tt/Mlzd043

This JAMA Forum highlights the 2 leading Medicare for All proposals currently in Congress and reviews how they would differ from the existing Medicare program. from JAMA Health Forum New Online https://ift.tt/qGANnsv